Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Nov 2:383:e076305.
doi: 10.1136/bmj-2023-076305.

Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial

Affiliations
Randomized Controlled Trial

Effects of a multimodal intervention in primary care to reduce second line antibiotic prescriptions for urinary tract infections in women: parallel, cluster randomised, controlled trial

Guido Schmiemann et al. BMJ. .

Abstract

Objectives: To evaluate whether a multimodal intervention in general practice reduces the proportion of second line antibiotic prescriptions and the overall proportion of antibiotic prescriptions for uncomplicated urinary tract infections in women.

Design: Parallel, cluster randomised, controlled trial.

Setting: General practices in five regions in Germany. Data were collected between 1 April 2021 and 31 March 2022.

Participants: General practitioners from 128 randomly assigned practices.

Interventions: Multimodal intervention consisting of guideline recommendations for general practitioners and patients, provision of regional data for antibiotic resistance, and quarterly feedback, which included individual first line and second line proportions of antibiotic prescribing, benchmarking with regional or supra-regional practices, and telephone counselling. Participants in the control group received no information on the intervention.

Main outcome measures: Primary outcome was the proportion of second line antibiotics prescribed by general practices, in relation to all antibiotics prescribed, for uncomplicated urinary tract infections after one year between the intervention and control group. General practices were randomly assigned in blocks (1:1), with a block size of four, into the intervention or control group using SAS version 9.4; randomisation was stratified by region. The secondary outcome was the prescription proportion of all antibiotics, relative within all cases (instances of UTI diagnosis), for the treatment of urinary tract infections after one year between the groups. Adverse events were assessed as exploratory outcomes.

Results: 110 practices with full datasets identified 10 323 cases during five quarters (ie, 15 months). The mean proportion of second line antibiotics prescribed was 0.19 (standard deviation 0.20) in the intervention group and 0.35 (0.25) in the control group after 12 months. After adjustment for preintervention proportions, the mean difference was -0.13 (95% confidence interval -0.21 to -0.06, P<0.001). The overall proportion of all antibiotic prescriptions for urinary tract infections over 12 months was 0.74 (standard deviation 0.22) in the intervention and 0.80 (0.15) in the control group with a mean difference of -0.08 (95% confidence interval -0.15 to -0.02, P<0.029). No differences were noted in the number of complications (ie, pyelonephritis, admission to hospital, or fever) between the groups.

Conclusions: The multimodal intervention in general practice significantly reduced the proportion of second line antibiotics and all antibiotic prescriptions for uncomplicated urinary tract infections in women.

Trial registration: German Clinical Trials Register (DRKS), DRKS00020389.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/and declare: support from Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee (G-BA) in Germany (grant no. 01VSF18053) for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Flow diagram of participating practices throughout the trial. The final analysis included 57 practices in the intervention group and 53 practices in the control group. Q=quarter
Fig 2
Fig 2
Proportions of second line antibiotic prescriptions in Qb-Q4. Percentiles: 10th (dashed line), 50th (solid line), and 90th percentile (dotted line). Q=quarter; Qb=baseline quarter
Fig 3
Fig 3
Relative frequencies of antibiotic agents in the control and intervention group in Qb and Q4. GPs=general practices; Q=quarter; Qb=baseline quarter*
Fig 4
Fig 4
Mean prescription proportions of second line antibiotics by quarter

Comment in

References

    1. Butler CC, Hawking MKD, Quigley A, McNulty CAM. Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey. Br J Gen Pract 2015;65:e702-7. 10.3399/bjgp15X686965 - DOI - PMC - PubMed
    1. Scottish Intercollegiate Guidelines Network (SIGN) . Management of suspected bacterial lower urinary tract infection in adult women. 2020. https://www.sign.ac.uk/our-guidelines/management-of-suspected-bacterial-...
    1. Kranz J, Schmidt S, Lebert C, Schneidewind L, Schmiemann G, Wagenlehner F. Uncomplicated bacterial community-acquired urinary tract infection in adults. Dtsch Arztebl Int 2017;114:866-73. 10.3238/arztebl.2017.0866 - DOI - PMC - PubMed
    1. Schmiemann G, Gebhardt K, Hummers E. Burning on micturition (Brennen beim Wasserlassen) guideline of the German College of General Practitioner and Family Physicians DEGAM, 2018. https://www.degam.de/degam-leitlinien-379
    1. Pouwels KB, Dolk FCK, Smith DRM, Robotham JV, Smieszek T. Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother 2018;73(suppl_2):19-26. 10.1093/jac/dkx502. - DOI - PMC - PubMed

Publication types

Substances